Back to Search
MICHAEL LIEBOWITZ, MD
MD
Psychiatry Physician
NPI: 1265578629Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
107862(NY)32813(NJ)
Clinical Trials (3)
3
Linked Trials
0
Recruiting
2
With Results
Cariprazine Versus Placebo for Social Anxiety Disorder
NCT05384483COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder
NCT01316302COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression
NCT00237666COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Ziprasidone monotherapy in bipolar II depression: an open trial.
PMID 19264363·J Affect Disord·2009
3-trial
A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
PMID 19358784·J Clin Psychiatry·2009
4-observational
Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder.
PMID 18507895·Curr Med Res Opin·2008
4-observational
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.
PMID 18052559·J Clin Psychiatry·2007
3-trial
A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.
PMID 15705011·J Clin Psychiatry·2005
3-trial
Integrating neurobiology and psychopathology into evidence-based treatment of social anxiety disorder.
PMID 16404800·CNS Spectr·2005
7-preclinical
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
PMID 15699296·Arch Gen Psychiatry·2005
3-trial
Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.
PMID 12934979·J Clin Psychiatry·2003
3-trial
A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.
PMID 11838629·J Clin Psychiatry·2002
3-trial
Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.
PMID 12447029·J Am Acad Child Adolesc Psychiatry·2002
3-trial
Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls.
PMID 18800368·Depress Anxiety·2009
8-other
Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale.
PMID 18781659·Depress Anxiety·2009
8-other
Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.
PMID 19180583·Depress Anxiety·2009
8-other
Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
PMID 19194995·Depress Anxiety·2009
2-rct
A double-masked, placebo-controlled study of fluoxetine for hypochondriasis.
PMID 19011432·J Clin Psychopharmacol·2008
4-observational
A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
PMID 18316422·Am J Psychiatry·2008
2-rct
Long-term follow-up study of patients with refractory obsessive-compulsive disorder.
PMID 19196930·J Neuropsychiatry Clin Neurosci·2008
8-other
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.
PMID 18949648·World J Biol Psychiatry·2008
6-review
Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
PMID 18557666·J Clin Psychiatry·2008
8-other
Distorted maternal mental representations and atypical behavior in a clinical sample of violence-exposed mothers and their toddlers.
PMID 18985165·J Trauma Dissociation·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14 EAST 90TH ST, SUITE 1A
NEW YORK, NY 10128 - Phone
- (212) 876-9881
Quick Facts
- NPI
- 1265578629
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Clinical Trials
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile